CETP inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – N-c doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S478000, C558S001000, C558S233000, C558S234000, C558S241000, C560S027000

Reexamination Certificate

active

07935727

ABSTRACT:
Compounds having a biphenyl group substituted with a phenyl or heteroaromatic group, as shown in Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol, and for treating or preventing atherosclerosis:

REFERENCES:
patent: 5599952 (1997-02-01), Matsumoto et al.
patent: 6458803 (2002-10-01), Sikorski et al.
patent: 2004/0058903 (2004-03-01), Takasugi et al.
patent: 2004/0082658 (2004-04-01), Harter et al.
patent: 2004/0220231 (2004-11-01), Lee et al.
patent: 2004/0229957 (2004-11-01), Shinkai et al.
patent: WO 2005/100298 (2005-10-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CETP inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CETP inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CETP inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2673998

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.